Grigorios Siokas Acquires 388,532 Shares of Cosmos Health (NASDAQ:COSM) Stock

Posted by Nicole Kennedy on Feb 15th, 2026

Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 388,532 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The stock was bought at an average price of $0.37 per share, for a total transaction of $143,756.84. Following the acquisition, the chief executive officer directly owned 8,861,914 shares of the company’s stock, valued at $3,278,908.18. The trade was a 4.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Grigorios Siokas also recently made the following trade(s):

On Wednesday, February 11th, Grigorios Siokas bought 291,262 shares of Cosmos Health stock. The shares were bought at an average price of $0.41 per share, with a total value of $119,417.42.
On Friday, January 23rd, Grigorios Siokas purchased 90,325 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.50 per share, for a total transaction of $45,162.50.
On Tuesday, January 20th, Grigorios Siokas purchased 353,321 shares of Cosmos Health stock. The stock was purchased at an average price of $0.50 per share, for a total transaction of $176,660.50.
On Wednesday, January 14th, Grigorios Siokas acquired 493,495 shares of Cosmos Health stock. The shares were purchased at an average price of $0.45 per share, with a total value of $222,072.75.
On Monday, January 12th, Grigorios Siokas bought 113,185 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.50 per share, for a total transaction of $56,592.50.
On Thursday, January 8th, Grigorios Siokas bought 156,190 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.52 per share, for a total transaction of $81,218.80.
On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The shares were purchased at an average price of $0.52 per share, with a total value of $64,937.60.
On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.54 per share, with a total value of $72,334.62.
On Friday, December 19th, Grigorios Siokas acquired 88,314 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.49 per share, for a total transaction of $43,273.86.
On Monday, December 15th, Grigorios Siokas bought 168,472 shares of Cosmos Health stock. The shares were acquired at an average price of $0.42 per share, with a total value of $70,758.24.

Cosmos Health Stock Up 2.7%

Shares of COSM stock opened at $0.38 on Friday. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. Cosmos Health Inc. has a 12 month low of $0.28 and a 12 month high of $1.32. The stock has a market cap of $14.35 million, a P/E ratio of -0.51 and a beta of 5.36. The company has a 50 day simple moving average of $0.48 and a two-hundred day simple moving average of $0.73.

Cosmos Health (NASDAQ:COSM – Get Free Report) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. The business had revenue of $17.11 million for the quarter, compared to the consensus estimate of $16.40 million. On average, research analysts expect that Cosmos Health Inc. will post -0.78 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Cosmos Health presently has a consensus rating of “Sell”.

Read Our Latest Report on Cosmos Health

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC raised its stake in shares of Cosmos Health Inc. (NASDAQ:COSM – Free Report) by 133.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 225,507 shares of the company’s stock after buying an additional 128,776 shares during the quarter. Citadel Advisors LLC owned about 0.65% of Cosmos Health worth $250,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 12.61% of the stock is owned by institutional investors and hedge funds.

About Cosmos Health

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.